EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fair and Square: Design, Synthesis and Biological Evaluations of Squaric Acid Derivatives as Novel HDAC8 Inhibitors

Nathan Long iD, Franz-Josef Meyer-Almes iD, Aleksandra Kopranovic, Stephen P Wren iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.70270 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Nathan Long und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Pharmacy and Chemistry, Faculty of Health, Science, Social Care and Education, Kingston University London, Kingston, UK. Hauptthemen laut MEDLINE: Cyclobutanes, Histone Deacetylase Inhibitors, Histone Deacetylases, Drug Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histone deacetylase 8 (HDAC8) is a clinically validated target in neuroblastoma, where isoform selective inhibition offers a strategy to suppress tumour growth while limiting off‐target toxicity. Hydroxamic acids remain the dominant zinc‐binding group (ZBG) in HDAC inhibitors but are also associated with metabolic instability, suboptimal pharmacokinetics and nonspecific metal chelation. In this study, we report the biological evaluation of a focussed library of 51 squaric acid derivatives as alternative, non‐hydroxamic HDAC inhibitors. While a subset of these compounds has been described previously in a synthetic context, their HDAC inhibitory activity and selectivity have not been reported to date. The compounds organised into four structural subfamilies were screened against HDAC8 with moderate isoform selectivity. Structure activity relationships, supported by molecular docking and in silico techniques, highlight the influence of substitution pattern, electronic properties and molecular rigidity on HDAC8 inhibition. Collectively, these findings establish squaric acid derivatives as a viable non‐hydroxamic acid scaffold for the development of selective HDAC inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclobutanesHistone Deacetylase InhibitorsHistone DeacetylasesDrug DesignRepressor ProteinsHumansStructure-Activity RelationshipMolecular Docking SimulationMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

HDACbioisosteresquaramidesquaric acid

Substanzen

CyclobutanesHistone Deacetylase InhibitorsHDAC8 protein, humansquaric acidHistone DeacetylasesRepressor Proteins

Autor:innen und Institutionen

  • School of Life Sciences, Pharmacy and Chemistry, Faculty of Health, Science, Social Care and Education, Kingston University London, Kingston, UK.
  • Department of Chemical Engineering and Biotechnology, University of Applied Sciences Darmstadt, Darmstadt, Germany.

ORCID-Profile: Nathan Long, Franz-Josef Meyer-Almes, Stephen P Wren

Zitieren

APA

Long, N., Meyer-Almes, F. J., Kopranovic, A., & Wren, S. P. (2026). Fair and Square: Design, Synthesis and Biological Evaluations of Squaric Acid Derivatives as Novel HDAC8 Inhibitors. ChemMedChem. https://doi.org/10.1002/cmdc.70270

Vancouver

Long N, Meyer-Almes FJ, Kopranovic A, Wren SP. Fair and Square: Design, Synthesis and Biological Evaluations of Squaric Acid Derivatives as Novel HDAC8 Inhibitors. ChemMedChem. 2026. doi:10.1002/cmdc.70270

BibTeX
@article{Long2026,
  author = {Long, Nathan and Meyer-Almes, Franz-Josef and Kopranovic, Aleksandra and Wren, Stephen P},
  title = {Fair and Square: Design, Synthesis and Biological Evaluations of Squaric Acid Derivatives as Novel HDAC8 Inhibitors},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70270}
}
Kostenlos starten →